Kurs & Likviditet
Prenumeration
Kalender
2024-11-06 | Kvartalsrapport 2024-Q3 |
2024-08-26 | Kvartalsrapport 2024-Q2 |
2024-05-17 | Ordinarie utdelning SEZI 0.00 SEK |
2024-05-16 | Årsstämma 2024 |
2024-05-07 | Kvartalsrapport 2024-Q1 |
2024-02-15 | Bokslutskommuniké 2023 |
2023-11-28 | Extra Bolagsstämma 2023 |
2023-10-26 | Kvartalsrapport 2023-Q3 |
2023-08-24 | Kvartalsrapport 2023-Q2 |
2023-05-17 | Ordinarie utdelning SEZI 0.00 SEK |
2023-05-16 | Årsstämma 2023 |
2023-04-28 | Kvartalsrapport 2023-Q1 |
2023-02-20 | Bokslutskommuniké 2022 |
2023-02-16 | Extra Bolagsstämma 2022 |
2022-11-10 | Kvartalsrapport 2022-Q3 |
2022-07-15 | Kvartalsrapport 2022-Q2 |
2022-05-19 | Ordinarie utdelning SEZI 0.00 SEK |
2022-05-18 | Årsstämma 2022 |
2022-05-05 | Kvartalsrapport 2022-Q1 |
2022-02-17 | Bokslutskommuniké 2021 |
2021-11-12 | Kvartalsrapport 2021-Q3 |
2021-08-27 | Kvartalsrapport 2021-Q2 |
2021-05-12 | Ordinarie utdelning SEZI 0.00 SEK |
2021-05-11 | Årsstämma 2021 |
2021-05-06 | Kvartalsrapport 2021-Q1 |
2021-03-05 | Extra Bolagsstämma 2021 |
2021-02-26 | Bokslutskommuniké 2020 |
2020-11-06 | Kvartalsrapport 2020-Q3 |
2020-08-21 | Kvartalsrapport 2020-Q2 |
2020-07-02 | Extra Bolagsstämma 2020 |
2020-05-15 | Ordinarie utdelning SEZI 0.00 SEK |
2020-05-14 | Årsstämma 2020 |
2020-05-08 | Kvartalsrapport 2020-Q1 |
2020-02-14 | Bokslutskommuniké 2019 |
2019-11-08 | Kvartalsrapport 2019-Q3 |
2019-08-22 | Kvartalsrapport 2019-Q2 |
2019-08-21 | Extra Bolagsstämma 2019 |
2019-05-09 | Ordinarie utdelning SEZI 0.00 SEK |
2019-05-08 | Kvartalsrapport 2019-Q1 |
2019-05-08 | Årsstämma 2019 |
2019-02-15 | Bokslutskommuniké 2018 |
2018-11-08 | Kvartalsrapport 2018-Q3 |
2018-08-22 | Kvartalsrapport 2018-Q2 |
2018-05-09 | Ordinarie utdelning SEZI 0.00 SEK |
2018-05-08 | Kvartalsrapport 2018-Q1 |
2018-05-08 | Årsstämma 2018 |
2018-03-05 | Extra Bolagsstämma 2018 |
2018-02-16 | Bokslutskommuniké 2017 |
2017-11-28 | Kvartalsrapport 2017-Q3 |
2017-09-15 | Extra Bolagsstämma 2017 |
2017-08-31 | Kvartalsrapport 2017-Q2 |
2017-05-23 | Kvartalsrapport 2017-Q1 |
2017-05-23 | Årsstämma 2017 |
2017-02-16 | Bokslutskommuniké 2016 |
2016-11-22 | Kvartalsrapport 2016-Q3 |
2016-08-31 | Kvartalsrapport 2016-Q2 |
2016-05-17 | Extra Bolagsstämma 2016 |
2016-04-28 | Ordinarie utdelning SEZI 0.00 SEK |
2016-04-27 | Kvartalsrapport 2016-Q1 |
2016-04-27 | Årsstämma 2016 |
2016-02-18 | Bokslutskommuniké 2015 |
2015-11-24 | Kvartalsrapport 2015-Q3 |
2015-08-26 | Kvartalsrapport 2015-Q2 |
2015-05-20 | Ordinarie utdelning SEZI 0.00 SEK |
2015-05-19 | Årsstämma 2015 |
2015-05-19 | Kvartalsrapport 2015-Q1 |
2015-02-25 | Bokslutskommuniké 2014 |
2014-11-27 | Kvartalsrapport 2014-Q3 |
2014-11-21 | Extra Bolagsstämma 2014 |
2014-08-21 | Kvartalsrapport 2014-Q2 |
2014-05-15 | Ordinarie utdelning SEZI 0.00 SEK |
2014-05-14 | Kvartalsrapport 2014-Q1 |
2014-05-14 | Årsstämma 2014 |
2014-02-24 | Bokslutskommuniké 2013 |
2013-11-27 | Kvartalsrapport 2013-Q3 |
2013-08-20 | Kvartalsrapport 2013-Q2 |
2013-05-16 | Ordinarie utdelning SEZI 0.00 SEK |
2013-05-15 | Kvartalsrapport 2013-Q1 |
2013-05-15 | Årsstämma 2013 |
2013-02-28 | Bokslutskommuniké 2012 |
2013-01-08 | Extra Bolagsstämma 2013 |
2012-11-21 | Kvartalsrapport 2012-Q3 |
2012-08-21 | Kvartalsrapport 2012-Q2 |
2012-05-24 | Ordinarie utdelning SEZI 0.00 SEK |
2012-05-23 | Årsstämma 2012 |
2012-05-23 | Kvartalsrapport 2012-Q1 |
2012-02-22 | Bokslutskommuniké 2011 |
2011-11-23 | Kvartalsrapport 2011-Q3 |
2011-08-23 | Kvartalsrapport 2011-Q2 |
2011-05-27 | Ordinarie utdelning SEZI 0.00 SEK |
2011-05-26 | Kvartalsrapport 2011-Q1 |
2011-05-26 | Årsstämma 2011 |
2011-02-16 | Bokslutskommuniké 2010 |
2010-11-24 | Kvartalsrapport 2010-Q3 |
2010-05-28 | Ordinarie utdelning SEZI 0.00 SEK |
2010-05-27 | Kvartalsrapport 2010-Q1 |
2009-11-25 | Kvartalsrapport 2009-Q3 |
Beskrivning
Land | Sverige |
---|---|
Lista | Small Cap Stockholm |
Sektor | Hälsovård |
Industri | Medicinteknik |
Press release: Uppsala March 24, 2022. Senzime announces today that the company has won an order from a large American academic healthcare system in the upper Midwest. This is a three-hospital facility affiliated with a School of Medicine. The order includes TetraGraph systems with associated disposable sensors at an initial order value exceeding SEK 1 million.
All operating rooms at the hospitals are equipped with TetraGraph systems. At the same time, the surgical protocol is standardized for patients who receive muscle-blocking drugs with a requirement that these will be monitored. The hospitals annually perform around 11 000 surgeries where these drugs are administered. Future recurrent TetraSens sales will be in addition to the initial order.
“Most hospitals today continuously and objectively measure critical parameters such as heart rate, blood pressure, oxygen levels and depth of anesthesia. Paralytic management should of course be measured with the same degree of accuracy. It is encouraging to see that more and more hospitals are standardizing objective monitoring of this vital function.”, says Pia Renaudin, CEO of Senzime
For further information, please contact:
Pia Renaudin, CEO of Senzime AB
Phone: +46 (0) 70-813 34 17, email: pia.renaudin@senzime.com
About Senzime
Senzime is a Swedish medical device company that develops and markets CE- and FDA-cleared monitoring systems for patients undergoing anesthesia. Senzime’s employees worldwide are committed to the vision of a world without anesthesia related complications. Six out of ten patients that wake up after surgery are not fully muscle recovered and therefor at risk having critical respiratory complications. The TetraGraph system helps anesthesia providers improve patient care and reduce healthcare costs by digitally and continuously measure the degree of neuromuscular blockade under and after surgery. Senzime operates in the worlds leading markets targeting a market opportunity valued in excess of SEK 15 billion per year. The company’s shares are listed on Nasdaq Stockholms main market (ticker SEZI). www.senzime.com